Fig 1.
Decision analytic model to estimate economic and disease burden of snakebite in ASEAN countries.
Abbreviation: ADR–adverse drug reaction.
Table 1.
Estimated economic and clinical impact of snakebite victims between current access and full access to snake antivenom in ASEAN countries.
Table 2.
Cost-effectiveness of improving access to snake antivenom in ASEAN countries.
Fig 2.
Cost-effectiveness acceptability curves of improving access to snake antivenom in ASEAN countries.
Probabilities of full access to snake antivenom being cost-effective compared to current access in each ASEAN country at varying willingness-to-pay thresholds based on 1,000 iterations of a probabilistic sensitivity analysis are presented.